QF
QVT Financial Portfolio holdings
AUM
$716M
This Quarter Return
+5.53%
1 Year Return
+15.53%
3 Year Return
+157.62%
5 Year Return
+333.57%
10 Year Return
+571.64%
AUM
$1.2B
AUM Growth
-$1.23B
(-51%)
Cap. Flow
-$1.74B
Cap. Flow
% of AUM
-145.33%
Top 10 Holdings %
Top 10 Hldgs %
40.76%
Holding
94
New
11
Increased
20
Reduced
8
Closed
15
Top Buys
| 1 |
SNDK
SANDISK CORP
SNDK
|
$29.5M |
| 2 |
YOKU
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
|
$21.9M |
| 3 |
NRE
NorthStar Realty Europe Corp.
NRE
|
$19.5M |
| 4 |
Marvell Technology
MRVL
|
$10.6M |
| 5 |
Zillow
Z
|
$9.98M |
Top Sells
| 1 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
$969M |
| 2 |
Arbutus Biopharma
ABUS
|
$97.5M |
| 3 |
eBay
EBAY
|
$31M |
| 4 |
Cal-Maine
CALM
|
$25.7M |
| 5 |
VNET
VNET Group
VNET
|
$21.3M |
Sector Composition
| 1 | Healthcare | 17.47% |
| 2 | Real Estate | 7.11% |
| 3 | Communication Services | 5.76% |
| 4 | Technology | 5.68% |
| 5 | Financials | 5.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPRX
26
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $10.2M | 0.58% |
246,848
-121,514
| -33% | -$5.04M |
|
|
27
Zillow
Z
$20.4B
| $9.98M | 0.56% |
+425,000
| New | +$9.98M |
|
|
NXEO
28
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
| $9.96M | 0.56% |
1,000,000
| – | – |
|
|
EPZM
29
DELISTED
Epizyme, Inc
EPZM
| $9.54M | 0.54% |
595,314
-58,514
| -9% | -$937K |
|
30
Wayfair
W
$10.4B
| $9.52M | 0.53% |
200,000
+25,000
| +14% | +$1.19M |
|
31
Zillow
ZG
$19.7B
| $9.11M | 0.51% |
350,000
+250,000
| +250% | +$6.51M |
|
|
BONA
32
DELISTED
BONA FILM GROUP LTD SPONSORED ADS
BONA
| $8.46M | 0.47% |
639,211
| – | – |
|
33
Halozyme
HALO
$8.81B
| $8.43M | 0.47% |
486,276
| – | – |
|
34
BRF SA
BRFS
$5.88B
| $8.39M | 0.47% |
607,112
| – | – |
|
35
JPMorgan Chase
JPM
$825B
| $8.38M | 0.47% |
126,879
+36,879
| +41% | +$2.44M |
|
|
FCSC
36
DELISTED
Fibrocell Science Inc.
FCSC
| $8.34M | 0.47% |
127,577
+2,873
| +2% | +$188K |
|
|
ADAP
37
Adaptimmune Therapeutics
ADAP
$13.1M
| $8.03M | 0.45% |
665,566
+315,566
| +90% | +$3.81M |
|
|
MRTX
38
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $7.94M | 0.45% |
251,137
-26,596
| -10% | -$840K |
|
|
BLCM
39
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $6.91M | 0.39% |
34,099
+2,325
| +7% | +$471K |
|
40
Xencor
XNCR
$585M
| $5.66M | 0.32% |
386,925
| – | – |
|
|
GNMX
41
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $5.22M | 0.29% |
867,608
+600,000
| +224% | +$3.61M |
|
42
Regenxbio
RGNX
$489M
| $5.19M | 0.29% |
+351,525
| New | +$5.19M |
|
|
EJ
43
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
| $5.1M | 0.29% |
810,400
| – | – |
|
44
Sarepta Therapeutics
SRPT
$1.95B
| $4.78M | 0.27% |
+123,850
| New | +$4.78M |
|
45
Golar LNG
GLNG
$4.49B
| $4.74M | 0.27% |
300,283
+46,558
| +18% | +$735K |
|
46
Energy Select Sector SPDR Fund
XLE
$27.2B
| $4.52M | 0.25% |
75,000
-129,628
| -63% | -$7.82M |
|
47
PTC Therapeutics
PTCT
$4.45B
| $3.81M | 0.21% |
+117,600
| New | +$3.81M |
|
|
BLUE
48
DELISTED
bluebird bio
BLUE
| $3.79M | 0.21% |
4,555
-4,543
| -50% | -$3.78M |
|
49
DHT Holdings
DHT
$1.93B
| $3.73M | 0.21% |
+460,522
| New | +$3.73M |
|
|
AKTX
50
Akari Therapeutics
AKTX
$22.5M
| $3.64M | 0.2% |
+13,196
| New | +$3.64M |
|